Bariatric Surgeon Who Lost 50 Pounds on Tirzepatide Defends Statins and GLP-1s
Dr. Terry Simpson brings personal experience with FH, tirzepatide, and statins to a blunt takedown of health misinformation.
Summary
Bariatric surgeon Dr. Terry Simpson joins Simon Hill to cut through popular health myths surrounding GLP-1 medications, statins, seed oils, and the carnivore diet. Simpson, who has familial hypercholesterolemia and lost 50 pounds on tirzepatide, brings unusual personal stakes to these debates. He defends Ancel Keys and the Mediterranean diet, explains how ApoB — not inflammation — is the primary driver of heart attacks, and shares how statin therapy brought his LDL from 190 down to the 40s. The episode also covers the risks of compounded GLP-1 drugs, why FDA oversight of peptides matters, and how to spot misinformation from health influencers. A nuanced, evidence-grounded conversation for anyone navigating conflicting nutrition and cardiovascular advice.
Detailed Summary
Health misinformation is one of the fastest-growing threats to public health, and few voices are better positioned to counter it than clinicians with skin in the game. This episode of The Proof with Simon Hill features bariatric surgeon and science communicator Dr. Terry Simpson, who brings both clinical expertise and a personal health history — familial hypercholesterolemia, a family history of premature cardiovascular disease, and his own 50-pound weight loss on tirzepatide — to a wide-ranging discussion on some of the most contested topics in modern medicine.
The conversation opens with a framework for identifying health misinformation and why contrarian voices tend to dominate social media despite being scientifically fringe. Simpson offers practical heuristics for evaluating health claims and explains why the loudest critics of mainstream medicine are often the least reliable.
On cardiovascular health, Simpson makes a compelling personal case for statin therapy. His LDL was 190 before treatment; it now sits in the 40s, with ApoB similarly reduced. He draws a clear mechanistic distinction between ApoB-driven atherosclerosis and inflammation, arguing that public confusion on this point is actively dangerous. He also defends Ancel Keys and the Mediterranean diet, citing the PREDIMED trial — which was halted early due to overwhelming cardiovascular benefit — as among the strongest dietary evidence available.
On GLP-1 medications, Simpson explains the origin of tirzepatide and similar drugs, clarifies the difference between native and pharmacological GLP-1 signaling, and addresses what 'food noise' actually means from a lived experience perspective. He raises serious safety concerns about compounded GLP-1 drugs and unregulated peptides like BPC-157, arguing that FDA oversight exists for good reason.
Caveats apply: this is a podcast episode, not peer-reviewed research. The discussion reflects the clinical opinions and personal experiences of the guests rather than new experimental data. Listeners should treat it as informed commentary rather than primary evidence.
Key Findings
- Statin therapy reduced Simpson's LDL from 190 to the 40s; ApoB, not inflammation, is the primary driver of heart attacks.
- Tirzepatide helped Simpson lose 50 pounds; 'food noise' suppression is a key mechanism often misunderstood by critics.
- The PREDIMED Mediterranean diet trial was stopped early due to overwhelming cardiovascular benefit.
- Compounded GLP-1 drugs and unregulated peptides like BPC-157 carry real safety risks despite their online popularity.
- Carnivore, anti-statin, and seed oil narratives are identified as among the most harmful current health misinformation trends.
Methodology
This is a long-form podcast episode featuring expert clinical commentary rather than a controlled study. Dr. Simpson draws on published trials, personal clinical experience, and his own health history. No new data are generated; arguments are grounded in existing evidence including PREDIMED and cardiovascular lipidology literature.
Study Limitations
This is a podcast episode reflecting expert opinion and personal anecdote, not peer-reviewed research or a systematic review. Claims about diet, statins, and GLP-1s are grounded in published literature but are not independently verified within this format. Listeners should consult primary sources and individual clinical context before making treatment decisions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.